IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
about
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsDownregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis.Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway.Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination.Basic fibroblast growth factor promotes melanocyte migration via activating PI3K/Akt-Rac1-FAK-JNK and ERK signaling pathways.A microfluidic dual gradient generator for conducting cell-based drug combination assays.RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.Neddylation controls basal MKK7 kinase activity in breast cancer cells.Astaxanthin induces migration in human skin keratinocytes via Rac1 activation and RhoA inhibition.Kaempferol-3-O-rutinoside from Afgekia mahidoliae promotes keratinocyte migration through FAK and Rac1 activation.The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
P2860
Q27311589-DFB28912-67FC-4141-A35F-C94378DD68D7Q33881209-57DBB03B-9C1F-474B-AC7B-2DF69E9D9A80Q34786561-0BA723C0-D72E-4C11-909F-A43212F67E21Q37362793-8161519D-07BC-4B0A-AFF2-A7E3838C5E39Q37564314-AF7436AD-6ADD-49BF-ADBF-605B46037C87Q37694339-8E8FC025-0C99-4204-9DF4-D2B64FF785CAQ37696985-E4A994AE-0715-46B2-B115-05AF5197C9FAQ38592713-730262FB-4DBD-4DF7-ACCF-73AC73423011Q38751482-DF210536-2D5A-408F-90F8-9FC5E82ECF9DQ38761387-8BE3AFCB-B375-4563-9246-D4D0EC8408B5Q38819479-4F9453A4-423A-4234-8ED2-8A1B669558E9Q38922299-D079579B-4D5D-4AA6-B73E-EB2BE6FA8CE4Q40545035-160FD12E-30C2-4A31-BE71-E780C6CD05CEQ41193402-9A607FD6-23C8-41FE-9FC3-FD3BD367D1C1Q41201511-D84FB9A9-3FF4-4D3E-90C4-297020D58D0CQ55024083-BB411A7C-FA56-449B-9C9A-55D014C79A11
P2860
IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@ast
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@en
type
label
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@ast
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@en
prefLabel
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@ast
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@en
P2093
P2860
P356
P1433
P1476
IBP regulates epithelial-to-me ...... and Cdc42 signaling pathways.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.337
P407
P577
2013-08-26T00:00:00Z
P5875
P6179
1037177997